Frequency Therapeutics Inc Earnings

The next earnings date for Frequency Therapeutics Inc has not yet been scheduled.

Analyst Estimates of Frequency Therapeutics Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Frequency Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/12/2025---$-2.74-5.61%
05/12/2025Before Market$-2.495.01%
03/24/2025Before Market$-2.2610.06%
11/01/2024After Market$-2.2613.41%
08/08/2024Before Market$-2.43-1.62%
05/14/2024After Market$-2.442.79%
03/26/2024After Market$-25.65-986.86%
11/02/2023After Market$-15.5012.58%
08/10/2023---$-0.3016.67%
05/12/2023---$-0.55-30.95%
03/10/2023---$-0.4922.35%
11/08/2022---$-0.553.51%
08/09/2022---$-0.618.04%
05/04/2022---$-0.67-5.36%
03/15/2022---$-0.62-506.02%
11/15/2021---$-0.73-23.94%
08/12/2021---$-0.52-2.24%
05/13/2021---$-0.60-536.36%
03/29/2021---$-0.30-18.11%
11/16/2020---$-0.1642.34%
08/12/2020---$-0.190.00%
05/14/2020---$-0.165.88%
03/26/2020---$-0.19-290.00%
11/18/2019---$-0.7378.66%
08/28/2019---$-6.67---

More About Frequency Therapeutics Inc

Country
USA
Full Time Employees
58

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Frequency Therapeutics Inc Earnings” Can Refer to the Frequency Therapeutics Inc Earnings Date

Some people say “Frequency Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Frequency Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Frequency Therapeutics Inc Stock on the Earnings Date

If you own Frequency Therapeutics Inc stock (KRRO) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Frequency Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Frequency Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Frequency Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Frequency Therapeutics Inc earnings or anything else related to the stock market.